ArticleInvestigational new drugs2015

Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors.

Sarah A Holstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.